A look at Hua Hong Semiconductor's long history, influential investors, and prospects competing against global chipmaking giants.
A Huahong Group stand at the International Technology Fair in Shanghai, China, May 7, 2013. Credit: Imaginechina via AP Images
Business is booming at Hua Hong Semiconductor, China’s second largest chipmaker, even as tech export controls by Western countries present major headwinds to the industry.
The Shanghai-based chipmaker last week announced a plan to launch a $4 billion joint venture to expand its production lines amid strong demand for its chips. The company also has plans to raise $2.5 billion on the Shanghai STAR Market, which would be the third largest ever IPO on the city’s tech-focused bourse.
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
At the height of the pandemic, Chinese vaccine maker Sinovac was a hero and one of the country’s most promising companies. But its success masked a protracted dispute between rival investors and management for control of the cash-rich company. The Wire China investigates what went wrong.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
